Skip to main content
logo
Oncopeptides AB (publ) (STO:ONCO)
Sweden flag Sweden · Delayed Price · Currency is SEK
5.35
+0.10 (1.90%)
At close: Dec 5, 2025

Oncopeptides AB Revenue

Oncopeptides AB had revenue of 20.21M SEK in the quarter ending September 30, 2025, with 137.62% growth. This brings the company's revenue in the last twelve months to 62.47M, up 130.75% year-over-year. In the year 2024, Oncopeptides AB had annual revenue of 31.65M, down -10.14%.

Revenue (ttm)
62.47M
Revenue Growth
+130.75%
P/S Ratio
23.36
Revenue / Employee
832.87K
Employees
80
Market Cap
1.46B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202431.65M-3.57M-10.14%
Dec 31, 202335.22M26.87M321.54%
Dec 31, 20228.36M-109.94M-92.94%
Dec 31, 2021118.30M--
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Getinge AB35.85B
Swedish Orphan Biovitrum AB27.85B
Medicover AB25.67B
Elekta AB17.57B
Asker Healthcare Group AB16.41B
AddLife AB10.53B
Nolato AB9.57B
Vitrolife AB3.51B
Revenue Rankings

Oncopeptides AB News

More News